MR

Marc Rosenberg

Healthcare Innovator | Investor

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Corporate Development
Strategic Planning
Business Strategy
Fundraising
Marketing
Clinical Research
Research
Treatment
Community Outreach
Statistics
Psychology
Neuroscience
Entrepreneurship
Leadership

Education

Work Experience

Northpond Ventures

2021 - 2024

  • Senior Associate

    2021 - 2024

    $2.2B Life Science VC - Focused on Healthcare Technology/Health Services, Life Science Tools and Diagnostics Board Affiliations Included: DNAnexus Eleanor Health Hawthorne Effect OPT Industries Outcomes4Me Torus Biosystems Ultivue

The Locus Initiative

2017 - 2023

  • Co-Founder and Strategic Advisor

    2017 - 2023

Elements Health Ventures

2019 - 2021

  • Investor

    2019 - 2021

    Digital Health and Healthcare Tech-enabled Services Merchant Banking Arm of MTS Health Partners

MTS Health Partners, L.P.

2019 - 2021

  • Investment Banking Analyst

    2019 - 2021

BioAlert Technologies

2018 - 2020

  • Founder and CEO

    2018 - 2020

    Founded in 2018 and based in Philadelphia, BioAlert Technologies was a development stage medical device company dedicated to the design and development of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients.